COMPLETE KIT INCLUDEDbacteriostatic water, syringes, protocol and guide with every order

Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•
BioPeptideX logoBioPeptideX
Back

Research guide · Recovery & Repair

Cartalax — research protocol

Short cartilage-targeting peptide (AEDL) studied for joint, cartilage and connective tissue regeneration.

Evidence boundary

This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.

Catalog presentations

20mg

Concentration table

Mathematical reference only; this is not a dosing recommendation.

Resulting concentration10.00 mg/mL
On a U-100 syringe · 1 unit contains0.100 mg

Research areas

  • Cartilage & joint targeted bioregulator peptide
  • Studied for chondrocyte regeneration and mobility
  • Lyophilized powder for maximum stability
  • 99% HPLC verified purity

Most-cited research protocols

Educational information based on research protocols and literature; it does not replace guidance from a healthcare professional.

Cartalax is a three-amino-acid peptide (Ala-Glu-Asp) with early laboratory research related to cartilage cells. It does not have a validated injectable human protocol or an FDA-approved dosage.

DoseFrequencyDurationRoute
Research Community Discussion2–5 mgonce dailynot specifiednot specified

Cycle: Unknown long-term effects; repeated injectable cycles have not been studied well enough to define long-term risk.

Benefits and research observations: The page does not specify a timeline for monitoring or expected outcomes beyond general research into cartilage-cell activity, chondrogenic markers, gene expression, and cellular aging.

Handling and storage

Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.

Warnings

Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.

Published sources

  1. 1.Khavinson VKh, et al. Bull Exp Biol Med, 2017.
  2. 2.Korkushko OV, et al. Adv Gerontol, 2019.